Stay Ahead of Compliance with Monthly Citation Updates


In your State Survey window and need a snapshot of your risks?

Survey Preparedness Report

One Time Fee
$79
  • Last 12 months of citation data in one tailored report
  • Pinpoint the tags driving penalties in facilities like yours
  • Jump to regulations and pathways used by surveyors
  • Access to your report within 2 hours of purchase
  • Easily share it with your team - no registration needed
Get Your Report Now →

Monthly citation updates straight to your inbox for ongoing preparation?

Monthly Citation Reports

$18.90 per month
  • Latest citation updates delivered monthly to your email
  • Citations organized by compliance areas
  • Shared automatically with your team, by area
  • Customizable for your state(s) of interest
  • Direct links to CMS documentation relevant parts
Learn more →

Save Hours of Work with AI-Powered Plan of Correction Writer


One-Time Fee

$29 per Plan of Correction
Volume discounts available – save up to 20%
  • Quickly search for approved POC from other facilities
  • Instant access
  • Intuitive interface
  • No recurring fees
  • Save hours of work
F0756
D

Failure to Communicate Pharmacist Lab Recommendations to Physician

Palm Desert, California Survey Completed on 02-06-2026

Penalty

No penalty information released
tooltip icon
The penalty, as released by CMS, applies to the entire inspection this citation is part of, covering all citations and f-tags issued, not just this specific f-tag. For the complete original report, please refer to the 'Details' section.

Summary

The deficiency involves the facility’s failure to ensure that a consultant pharmacist’s medication regimen review (MRR) recommendation was communicated to the physician for one resident. During an unannounced visit, surveyors reviewed the record of Resident A, who had diabetes mellitus and severe cognitive impairment with a BIMS score of 3. Resident A’s orders included Lantus 25 units at bedtime and Humalog insulin before meals and at bedtime per sliding scale, with a prior HgbA1C order and result of 10.5%. The Medication Administration Record from early January through early February showed blood glucose levels above 200 mg/dl with Humalog administered per sliding scale. The resident’s care plan documented hyperglycemia and poor glycemic control related to Type 2 diabetes mellitus, evidenced by the elevated HgbA1C and use of sliding scale insulin, with instructions to reassess nutritional status and glycemic control routinely. A review of the consultant pharmacist’s MRR dated December 22, 2025, showed a recommendation to clarify with the physician the need for HgbA1C and Vitamin D 25 OH lab tests. Further review of the resident’s record revealed no documented evidence that this recommendation was implemented or referred to the physician after it was made. In an interview, the DON confirmed that the pharmacy consultant’s recommendation for lab tests for this resident was not communicated to the physician and acknowledged that it should have been discussed. The facility’s Medication Regimen Review policy stated that the consultant pharmacist is to review each resident’s medication regimen monthly, identify and report medication-related problems and irregularities, and provide written reports to attending physicians, the DON, and the Medical Director, with copies and physician responses maintained in the permanent medical record. This process was not followed for Resident A’s recommended lab monitoring.

Long-term care team reviewing survey readiness and plan of correction

We Help Long-Term Care Teams Stay Survey-Ready

We process and analyze inspection reports and plan of correction using AI to extract insights and trends so providers can improve care quality and stay ahead of compliance risks.

Discover our solutions:

An unhandled error has occurred. Reload 🗙